REFRACTORY COLORECTAL ADENOCARCINOMA

Clinical trials for REFRACTORY COLORECTAL ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY COLORECTAL ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for REFRACTORY COLORECTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New hope for Tough-to-Treat colon cancer patients

Disease control Recruiting now

This early-stage study is testing whether adding an experimental drug called ZEN003694 to two existing cancer drugs (cetuximab and encorafenib) is safe and effective for people with advanced colorectal cancer that has stopped responding to previous treatments. The trial will enro…

Matched conditions: REFRACTORY COLORECTAL ADENOCARCINOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 11, 2026 14:54 UTC

REFRACTORY COLORECTAL ADENOCARCINOMA

Get alerted when new REFRACTORY COLORECTAL ADENOCARCINOMA trials appear

New hope for Tough-to-Treat colon cancer patients